Author Correction: Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Catherine J MummeryAnne Börjesson-HansonDaniel J BlackburnEverard G B VijverbergPeter Paul De DeynSimon DucharmeMichael JonssonAnja SchneiderJuha O RinneAlbert C LudolphRalf BodenschatzHolly KordasiewiczEric E SwayzeBethany FitzsimmonsLaurence MignonKatrina M MooreChris YunTiffany BaumannDan LiDaniel A NorrisRebecca CreanDanielle L GrahamEllen HuangElena RattiC Frank BennettCandice JungeRoger M LanePublished in: Nature medicine (2023)